Dulac Edward J III 4
4 · FATE THERAPEUTICS INC · Filed Dec 19, 2023
Insider Transaction Report
Form 4
Dulac Edward J III
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-12-18$3.50/sh−1,585$5,548→ 117,985 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 5, 2023.